Abstract
This study aimed to assess the inhibitory activities of methanol extracts from the microalgae Ankistrodesmus convolutus, Synechococcus elongatus, and Spirulina platensis against Epstein-Barr virus (EBV) in three Burkitt’s lymphoma (BL) cell lines, namely Akata, B95-8, and P3HR-1. The antiviral activity was assessed by quantifying the cell-free EBV DNA using real-time polymerase chain reaction (PCR) technique. The methanol extracts from Ankistrodesmus convolutus and Synechococcus elongatus displayed low cytotoxicity and potent effect in reducing cell-free EBV DNA (EC50<0.01 μg/ml) with a high therapeutic index (>28 000). After fractionation by column chromatography, the fraction from Synechococcus elongatus (SEF1) reduced the cell-free EBV DNA most effectively (EC50=2.9 μg/ml, therapeutic index>69). Upon further fractionation by high performance liquid chromatography (HPLC), the sub-fraction SEF1’a was most active in reducing the cell-free EBV DNA (EC50=1.38 μg/ml, therapeutic index>14.5). This study suggests that microalgae could be a potential source of antiviral compounds that can be used against EBV.
Similar content being viewed by others
References
Adamson, A.L., Darr, D., Holley-Guthrie, E., Johnson, R.A., Mauser, A., Swenson, J., Kenney, S., 2000. Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases. J. Virol., 74(3):1224–1233. [doi:10.1128/JVI.74.3.1224-1233.2000]
Akihisa, T., Taguchi, Y., Yasukawa, K., Tokuda, H., Akazawa, H., Suzuki, T., Kimura, Y., 2006. Acerogenin M, a cyclic diarylheptanoid, and other phenolic compounds from Acer nikoense and their anti-inflammatory and anti-tumor-promoting effects. Chem. Pharm. Bull., 54(5): 735–739. [doi:10.1248/cpb.54.735]
Ballout, M., Germi, R., Fafi-Kremer, S., Guimet, J., Bargues, G., Seigneurin, J., Morand, P., 2007. Real-time quantitative PCR for assessment of antiviral drug effects against Epstein-Barr virus replication and EBV late mRNA expression. J. Virol. Methods, 143(1):38–44. [doi:10.1016/j.jviromet.2007.02.005]
Buck, C.B., Thompson, C.D., Roberts, J.N., Müller, M., Lowy, D.R., Schiller, J.T., 2006. Carrageenan is a potent inhibitor of papillomavirus infection. PLoS Pathogens, 2(7):e69. [doi:10.1371/journal.ppat.0020069]
Chang, Y., Tung, C.H., Huang, Y.T., Lu, J., Chen, J.Y., Tsai, C.H., 1999. Requirement of cell to cell contact in EBV infection of NPC and keratinocytes. J. Virol., 73(10): 8857–8866.
Chêne, A., Donati, D., Guerreriro-Cacais, A.O., Levitsky, V., Chen, Q., Falk, K.I., Orem, J., Kironde, F., Wahlgren, M., Bejarano, M.T., 2007. A molecular link between malaria and Epstein-Barr virus reactivation. PLoS Pathogens, 3(6):e80. [doi:10.1371/journal.ppat.0030080]
Chu, W.L., Phang, S.M., Goh, S.H., 1995. Influence of carbon source on the growth, biochemical composition and pigmentation of Ankistrodesmus convolutus. J. Appl. Phycol., 7(1):59–64. [doi:10.1007/BF00003551]
Daibata, M., Bandobashi, K., Kuroda, M., Imai, S., Miyoshi, I., Taguchi, H., 2005. Induction of lytic Epstein-Barr virus (EBV) infection by synergistic action of rituximab and dexamethasone renders EBV-positive lymphoma cells more susceptible to ganciclovir cytotoxicity in vitro and in vivo. J. Virol., 79(9):5875–5879. [doi:10.1128/JVI.79.9.5875-5879.2005]
Fang, C.Y., Lee, C.H., Wu, C.C., Chang, Y.T., Yu, S.L., Chou, S.P., Huang, P.T., Chen, C.L., Hou, J.W., Chang, Y., et al., 2009. Recurrent chemical reactivations of EBV promotes genome instability and enhances tumor progression of nasopharyngeal carcinoma cells. Int. J. Cancer, 124(9): 2016–2025. [doi:10.1002/ijc.24179]
Feng, P., Ren, E.C., Liu, D., Chan, S.H., Hu, H., 2000. Expression of Epstein-Barr virus lytic gene BRLF1 in nasopharyngeal carcinoma: potential use in diagnosis. J. Gen. Virol., 81(Pt 10):2417–2423.
Gershburg, E., Pagano, J.S., 2005. Epstein-Barr virus infections: prospects for treatment. J. Antimicrob. Chemother., 56(2):277–281. [doi:10.1093/jac/dki240]
Hemmingson, J.A., Falshaw, R., Furneaux, R.H., Thompson, K., 2006. Structure and antiviral activity of the galactofucan sulfates extracted from Undaria pinnatifida (Phaeophyta). J. Appl. Phycol., 18(2):185–193. [doi:10.1007/s10811-006-9096-9]
Huleihel, M., Ishanu, V., Tal, J., Arad, S., 2001. Antiviral effect of red microalgal polysaccharides on Herpes simplex and Varicella zoster viruses. J. Appl. Phycol., 13(2): 127–134. [doi:10.1023/A:1011178225912]
Klein, G., 1994. Epstein-Barr virus strategy in normal and neoplastic B cells. Cell, 77(6):791–793. [doi:10.1016/0092-8674(94)90125-2]
Krenauer, A., Moll, A., Ponisch, W., Schmitz, N., Niedobitek, G., Niederwieser, D., Aigner, T., 2010. EBV-associated post-transplantation B-cell lymphoproliferative disorder following allogenic stem cell transplantation for acute lymphoblastic leukaemia: tumor regression after reduction of immunosuppression-a case report. Diagn. Pathol., 5(1):21. [doi:10.1186/1746-1596-5-21]
Kurth, J., Spieker, T., Wustrow, J., Strickler, G.J., Hansmann, L.M., Rajewsky, K., Küppers, R., 2000. EBV-infected B cells in infectious mononucleosis: viral strategies for spreading in the B cell compartment and establishing latency. Immunity, 13(4):485–495. [doi:10.1016/S1074-7613(00)00048-0]
Lai, P.J., Chu, W.L., Naidu, R., Khoo, A.S.B., Kok, Y.Y., Shar, M.M., Ling, S.N., Mak, J.W., Lim, K.C., Balraj, P., et al., 2008. Antiproliferative activity of microalgal extracts on nasopharyngeal carcinoma (NPC) cells. Malaysian J. Sci., 27(2):19–31.
Lin, J.C., 2003. Mechanism of action of glycyrrhizic acid in inhibition of Epstein-Barr virus replication in vitro. Antiviral Res., 59(1):41–47. [doi:10.1016/S0166-3542(03) 00030-5]
Lin, T.P., Chen, S.Y., Duh, P.D., Chang, L.K., Liu, Y.N., 2008. Inhibition of the Epstein-Barr virus lytic cycle by andrographolide. Biol. Pharm. Bull., 31(11):2018–2023. [doi: 10.1248/bpb.31.2018]
Lo, D.Y.M., Chan, L.Y.S., Lo, K.W., Leung, S.F., Zhang, J., Chan, A.T.C., Lee, J.C.K., Hjelm, N.M., Johnson, P.J., Huang, D.P., 1999. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res., 59:1188–1191.
Mosmann, T., 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65(1–2):55–63. [doi:10.1016/0022-1759(83)90303-4]
Ohigashi, H., Sakai, Y., Yamaguchi, K., Umezaki, I., Koshimizu, K., 1992. Possible anti-tumor promoting properties of marine algae and in vivo activity of Wakame seaweed extract. Biosci. Biotechnol. Biochem., 56(6):994–995. [doi:10.1271/bbb.56.994]
Phang, S.M., Chu, W.L., 1999. University of Malaya Algae Culture Collection (UMACC): Catalogue of Strains. Institute of Postgraduate Studies and Research, University of Malaya, Kuala Lumpur, Malaysia, p.77.
Rechter, S., König, T., Auerochs, S., Thulke, S., Walter, H., Dörnenburg, H., Walter, C., Marschall, M., 2006. Antiviral activity of Arthrospira-derived spirulan-like substances. Antiviral Res., 72(3):197–206. [doi:10.1016/j.antiviral.2006.06.004]
Rezk, S., Weiss, L., 2007. Epstein-Barr virus-associated lymphoproliferative disorders. Human Pathol., 38(9):1293–1304. [doi:10.1016/j.humpath.2007.05.020]
Rickinson, A.B., Kieff, E., 1996. Epstein-Barr Virus. In: Fields, B.N., Knipe, B.N., Howley, P.M. (Eds.), Fields Virology. Lippincott-Williams and Wilkins, Philadelphia, p.2397–2476.
Rocha, F.D., Soares, A.R., Houghton, P.J., Pereira, R.C., Kaplan, M.A.C., Teixeira, V.L., 2007. Potential cytotoxic activity of some Brazilian seaweeds on human melanoma cells. Phytother. Res., 21(2):170–175. [doi:10.1002/ptr.2038]
Schwarzmann, F., Jager, M., Horner, M., Prang, N., Wolf, H., 1998. Epstein-Barr viral gene expression in B-lymphocytes. Leuk. Lymphoma, 30(1–2):123–129.
Takada, K., Shimizu, N., Tanabe-Tochikura, A., Kuroiwa, Y., 1995. Pathogenic role of Epstein-Barr virus in human cancer. Intervirology, 38(3–4):214–220.
Walling, D.M., Flaitz, C.M., Nicholas, C.M., 2003. Epstein-Barr virus replication in oral hairy leukoplakia: response, persistence, and resistance to treatment with valacyclovir. J. Infect. Dis., 188(6):883–890. [doi:10.1086/378072]
Author information
Authors and Affiliations
Corresponding author
Additional information
Project (IRPA: 06-05-01-0000-PR0054105-04) supported by the Ministry of Science, Technology, and Innovation (MOSTI) of Malaysia
Rights and permissions
About this article
Cite this article
Kok, YY., Chu, WL., Phang, SM. et al. Inhibitory activities of microalgal extracts against Epstein-Barr virus DNA release from lymphoblastoid cells. J. Zhejiang Univ. Sci. B 12, 335–345 (2011). https://doi.org/10.1631/jzus.B1000336
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1631/jzus.B1000336
Key words
- Microalgae
- Ankistrodesmus convolutus
- Synechococcus elongatus
- Spirulina platensis
- Lymphoblastoid cells
- Epstein-Barr virus (EBV)